Letters

Depot medroxyprogesterone and bone density

BMJ 1994; 308 doi: https://doi.org/10.1136/bmj.308.6943.1567a (Published 11 June 1994) Cite this as: BMJ 1994;308:1567
  1. T Cundy,
  2. I Reid
  1. Department of Medicine, University of Auckland Medical School, Auckland 1, New Zealand.

    EDITOR, - It is gratifying when publications arouse a vigorous debate, but the comments of correspondents on our paper1 are disappointing. Either our writing is not clear or the correspondents have not read the paper properly.Anne Szarewiski and colleagues say that we described the theoretical risk of oestrogen deficiency and osteoporosis in long term users of depot medroxyprogesterone.2 Our study in fact showed that spinal bone density increased in women who stopped using depot medroxyprogesterone …

    View Full Text

    Sign in

    Log in through your institution

    Free trial

    Register for a free trial to thebmj.com to receive unlimited access to all content on thebmj.com for 14 days.
    Sign up for a free trial

    Subscribe